Director, Ted Rogers Program in Cardiotoxicity Prevention, Peter Munk Cardiac Center, TGH Toronto General Hospital University of Toronto
Session Description: Intersection of oncology and cardiology-what you need to know in 2023 1. The top 5 conditions you may encounter in your cardiac patient undergoing chemotherapy 2. Any role of biomarker monitoring and “prophylactic” pharmacotherapy to mitigate cardiotoxicity(BB,statin,ACEI)? 3. The very complex management of radiation induced heart disease 60 year old woman treated with radiation therapy 15 years ago for left sided breast cancer presents with class 2 angina, dyspnea and severe peripheral edema
